BACKGROUND: ABO blood type is an inherited trait associated with coagulation factor levels and vascular outcomes. OBJECTIVES: To assess the association of blood type with stroke and whether blood type contributes to racial disparities in stroke in the United States. PATIENTS AND METHODS: The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study recruited 30 239 participants between 2003 and 2007. Using a case-cohort design, blood type was genotyped in 646 participants with stroke and a 1104-participant cohort random sample. Cox models that adjusted for Framingham stroke risk factors were used to assess the association of blood type with stroke. RESULTS: During 5.8 years of follow-up, blood types A or B vs. type O were not associated with stroke. Blood type AB vs. O was associated with an increased risk of stroke (adjusted hazard ratio [HR] 1.83, 95% confidence interval [CI] 1.01-3.30). The association of blood type AB vs. O was greater in those without diabetes (adjusted HR 3.33, 95% CI 1.61-6.88) than those with diabetes (adjusted HR 0.49, 95% CI 0.17-1.44) (P interaction = 0.02). Factor VIII levels accounted for 60% (95% CI 11%-98%) of the association of AB blood type and stroke risk. CONCLUSION: Blood type AB is associated with an increased risk of stroke that is not attenuated by conventional stroke risk factors, and factor VIII levels were associated with 60% of the association. While blood type AB is rare in the US population, it is a significant stroke risk factor and may play an important role in stroke risk in these individuals.
BACKGROUND:ABO blood type is an inherited trait associated with coagulation factor levels and vascular outcomes. OBJECTIVES: To assess the association of blood type with stroke and whether blood type contributes to racial disparities in stroke in the United States. PATIENTS AND METHODS: The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study recruited 30 239 participants between 2003 and 2007. Using a case-cohort design, blood type was genotyped in 646 participants with stroke and a 1104-participant cohort random sample. Cox models that adjusted for Framingham stroke risk factors were used to assess the association of blood type with stroke. RESULTS: During 5.8 years of follow-up, blood types A or B vs. type O were not associated with stroke. Blood type AB vs. O was associated with an increased risk of stroke (adjusted hazard ratio [HR] 1.83, 95% confidence interval [CI] 1.01-3.30). The association of blood type AB vs. O was greater in those without diabetes (adjusted HR 3.33, 95% CI 1.61-6.88) than those with diabetes (adjusted HR 0.49, 95% CI 0.17-1.44) (P interaction = 0.02). Factor VIII levels accounted for 60% (95% CI 11%-98%) of the association of AB blood type and stroke risk. CONCLUSION: Blood type AB is associated with an increased risk of stroke that is not attenuated by conventional stroke risk factors, and factor VIII levels were associated with 60% of the association. While blood type AB is rare in the US population, it is a significant stroke risk factor and may play an important role in stroke risk in these individuals.
Authors: Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard Journal: Neuroepidemiology Date: 2005-06-29 Impact factor: 3.282
Authors: Tetsuya Ohira; Eyal Shahar; Lloyd E Chambless; Wayne D Rosamond; Thomas H Mosley; Aaron R Folsom Journal: Stroke Date: 2006-08-24 Impact factor: 7.914
Authors: Virginia J Howard; Dawn O Kleindorfer; Suzanne E Judd; Leslie A McClure; Monika M Safford; J David Rhodes; Mary Cushman; Claudia S Moy; Elsayed Z Soliman; Brett M Kissela; George Howard Journal: Ann Neurol Date: 2011-03-17 Impact factor: 10.422
Authors: K L Wiggins; N L Smith; N L Glazer; F R Rosendaal; S R Heckbert; B M Psaty; K M Rice; T Lumley Journal: J Thromb Haemost Date: 2008-11-25 Impact factor: 5.824
Authors: T Ohira; M Cushman; M Y Tsai; Y Zhang; S R Heckbert; N A Zakai; W D Rosamond; A R Folsom Journal: J Thromb Haemost Date: 2007-04-09 Impact factor: 5.824
Authors: Guillaume Paré; Daniel I Chasman; Mark Kellogg; Robert Y L Zee; Nader Rifai; Sunita Badola; Joseph P Miletich; Paul M Ridker Journal: PLoS Genet Date: 2008-07-04 Impact factor: 5.917
Authors: Wesley T O'Neal; Elsayed Z Soliman; George Howard; Virginia J Howard; Monika M Safford; Mary Cushman; Neil A Zakai Journal: Atherosclerosis Date: 2015-09-08 Impact factor: 5.162
Authors: Neil A Zakai; Nels C Olson; Suzanne E Judd; Dawn O Kleindorfer; Brett M Kissela; George Howard; Mary Cushman Journal: Thromb Haemost Date: 2017-07-06 Impact factor: 5.249
Authors: Nicholas B Larson; Elizabeth J Bell; Paul A Decker; Mindy Pike; Christina L Wassel; Michael Y Tsai; James S Pankow; Weihong Tang; Naomi Q Hanson; Kristine Alexander; Neil A Zakai; Mary Cushman; Suzette J Bielinski Journal: Atherosclerosis Date: 2016-06-07 Impact factor: 5.162
Authors: Nicholas B Larson; Paul A Decker; Christina L Wassel; James S Pankow; Weihong Tang; Naomi Q Hanson; Michael Y Tsai; Suzette J Bielinski Journal: Hum Genet Date: 2016-02-16 Impact factor: 4.132
Authors: Kristine S Alexander; Neil A Zakai; Sarah Gillett; Leslie A McClure; Virginia Wadley; Fred Unverzagt; Mary Cushman Journal: Neurology Date: 2014-09-10 Impact factor: 9.910
Authors: Martin D Zielinski; Jason J Schrager; Pamela Johnson; James R Stubbs; Stephanie Polites; Scott P Zietlow; Donald H Jenkins; Bryce R H Robinson Journal: Clin Transl Sci Date: 2014-09-09 Impact factor: 4.689